ASRT vs CB · rev $125.0M vs P/E 14, rev $59.40B
Assertio Therapeutics Inc (ASRT) versus Chubb Ltd (CB) — a side-by-side from cached financials, not a winner call.
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
ASRT currently screens at market cap $151.5M. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Not investment advice. Open the ASRT and CB stock pages for the full models.
Not investment advice.